Energy Dose-Response in Selective Laser Trabeculoplasty: A Review
- PMID: 35701875
- PMCID: PMC9362340
- DOI: 10.1097/IJG.0000000000002062
Energy Dose-Response in Selective Laser Trabeculoplasty: A Review
Abstract
Prcis: A literature review of selective laser trabeculoplasty (SLT) energy dose-response found no definitive relationship between intraocular pressure (IOP) reduction with respect to total or pulse energy, race, pigmentation, or application pattern.
Purpose: SLT is a safe and effective treatment for lowering IOP. Although evidence is mounting for the advantage of its use as a first-line treatment for IOP reduction, the SLT procedures in use vary widely. The purpose of this literature review was to investigate whether there were any relationships between SLT energy and efficacy for lowering IOP in the published literature.
Methods: A literature review was undertaken that included studies in which energy levels required for successful SLT treatment were investigated: in general, with respect to angle pigmentation, race or ethnicity, and treatment arc extent.
Results: There was no indication that higher (or lower) energy used in the treatment leads to greater (or less) IOP reduction. Similar results were obtained regarding the level of trabecular meshwork pigmentation. Race was not found to be associated with altered dose response in SLT. There were indications that treating the full 360 degrees, as opposed to smaller arcs, could be beneficial for more IOP reduction. IOP reduction from SLT was found to be similar to that provided by topical medications.
Conclusions: The optimal energy level of SLT needed for IOP reduction has not yet been definitively established, with all reported pulse energies resulting in similar IOP reduction. Furthermore, similar lack of conclusive findings exists regarding optimal SLT energy dosage for use in different races and degrees of trabecular meshwork pigmentation. This parameter and each of the abovementioned factors requires further research.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
Disclosure: M.A. is employed by SPRING Biomed Vision Ltd., serves as a consultant to Belkin Vision Ltd., and has received payment from Belkin Vision Ltd. for writing of this review. Z.S. serves as a consultant to Belkin Vision Ltd., has received payment from this company for writing the present review, and holds options in the company. M.B. is the founder of BELKIN Vision Ltd. and serves as a consultant to SPRING Biomed Vision Ltd. T.A., K.S., and T.S. are consultants to Belkin Vision Ltd. The remaining authors declare no conflict of interest.
Similar articles
-
Outcomes of Selective Laser Trabeculoplasty After Prior Incisional Surgery for Open Angle Glaucoma.J Glaucoma. 2023 Jun 1;32(6):474-479. doi: 10.1097/IJG.0000000000002196. Epub 2023 Feb 28. J Glaucoma. 2023. PMID: 36847694
-
Optimal selective laser trabeculoplasty energy for maximal intraocular pressure reduction in open-angle glaucoma.J Glaucoma. 2015 Jun-Jul;24(5):e128-31. doi: 10.1097/IJG.0000000000000215. J Glaucoma. 2015. PMID: 25651204
-
Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma.Ophthalmology. 2004 Oct;111(10):1853-9. doi: 10.1016/j.ophtha.2004.04.030. Ophthalmology. 2004. PMID: 15465546
-
Selective laser trabeculoplasty versus medication for open-angle glaucoma: systematic review and meta-analysis of randomised clinical trials.Br J Ophthalmol. 2020 Nov;104(11):1500-1507. doi: 10.1136/bjophthalmol-2019-315613. Epub 2020 Feb 12. Br J Ophthalmol. 2020. PMID: 32051136
-
Is laser trabeculoplasty the new star in glaucoma treatment?Curr Opin Ophthalmol. 2021 Mar 1;32(2):141-147. doi: 10.1097/ICU.0000000000000732. Curr Opin Ophthalmol. 2021. PMID: 33470670 Review.
Cited by
-
Mechanism of selective laser trabeculoplasty: a systemic review.Int J Ophthalmol. 2024 May 18;17(5):963-968. doi: 10.18240/ijo.2024.05.22. eCollection 2024. Int J Ophthalmol. 2024. PMID: 38766345 Free PMC article. Review.
-
Acute corneal edema and residual subepithelial haze after bilateral selective laser trabeculoplasty: A case series.Saudi J Ophthalmol. 2024 Dec 26;38(4):396-400. doi: 10.4103/sjopt.sjopt_152_24. eCollection 2024 Oct-Dec. Saudi J Ophthalmol. 2024. PMID: 39943961 Free PMC article.
-
Selective laser trabeculoplasty: An updated narrative review.Indian J Ophthalmol. 2024 Mar 1;72(3):312-319. doi: 10.4103/IJO.IJO_2104_23. Epub 2024 Feb 28. Indian J Ophthalmol. 2024. PMID: 38421290 Free PMC article. Review.
-
Outcomes of Micropulse Laser Trabeculoplasty Compared to Selective Laser Trabeculoplasty: A Systematic Review and Meta-Analysis.Clin Ophthalmol. 2024 Aug 6;18:2205-2215. doi: 10.2147/OPTH.S476257. eCollection 2024. Clin Ophthalmol. 2024. PMID: 39131544 Free PMC article. Review.
-
One-year outcomes of selective laser trabeculoplasty for open-angle glaucoma in Indian eyes.Indian J Ophthalmol. 2025 Mar 1;73(Suppl 2):S221-S225. doi: 10.4103/IJO.IJO_1434_24. Epub 2024 Dec 27. Indian J Ophthalmol. 2025. PMID: 39728672 Free PMC article.
References
-
- Tham YC, Li X, Wong TY, et al. . Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081–2090. - PubMed
-
- Jonas JB, Aung T, Bourne RR, et al. . Glaucoma. Lancet. 2017;390:2183–2193. - PubMed
-
- Krug J, Chiavelli M, Borawski G, et al. . The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results. Am J Ophthalmol. 1995;120:718–731. - PubMed
-
- Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116(suppl 11):S30–S36. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources